Type 1 Diabetes Clinical Research Network's Innovation Award

JDRF is pleased to announce that the Australian Type 1 Diabetes Clinical Research Network’s Innovation Award is open for applications.

Innovation Award
This Request for Applications (RFA) for the Innovation Award is open to the best and brightest researchers with innovative ideas that have the potential to improve the lives of people with type 1 diabetes, regardless of whether you are currently in the field of type 1 diabetes research or completely external to it. We are seeking innovative proposals describing cutting-edge innovation falling outside current type 1 diabetes research paradigms supported by collaborative teams.

This award provides project funding of up to $1.5M for a period of two to three years.

Apply
This first round of application is open to Letters of Intent (LOI) and will be reviewed by an independent panel of experts. Only shortlisted applicants will be invited to apply for full submission.

Please reference the RFA for more information.

Applications must be submitted via RMS360, our online grants management system. For information on how to register on RMS360and complete the online application, please refer to our User Guide. Please do not use Internet Explorer – only use Google Chrome and Mozilla Firefox when accessing RMS360.

Important dates and deadlines

LOI application opens LOI application deadline Invitation to full submission Full submission deadline** Interviews Notification to applicants	15 April 2016 22 July 2016 - 17:00 AEST 31 August 2016 26 October 2016 - 17:00 AEDT 6-7 December 2016 January 2017
**Applicants must note that the Research Office of each Administering Organisation is required to certify to JDRF all “full submission” applications in RMS360 and may have an internal closing time which precedes this deadline.

We strongly encourage all researchers who are considering submitting an LOI to contact us prior to application.

Help and support
For any further information, please contact Julia Warning via email or phone +61 2 9020 6105.
For RMS360 assistance, please contact Amy Brown via email or phone +61 2 9020 6139.

JDRF and the T1DCRN
JDRF is the leading global organisation funding research into autoimmune type 1 diabetes. The T1DCRN is an innovative clinical research program led by JDRF Australia, which brings together researchers, patients, industry and international networks to share a strong focus on patient benefit. The T1DCRN is supported by the Australian Government through the Special Research Initiative for Type 1 Juvenile Diabetes, a $35 million grant funded by the Australian Research Council. The T1DCRN is dedicated to positively impacting the life of people with type 1 diabetes through accelerating clinical research for the cure, treatment and prevention of type 1 diabetes.